Centessa Pharmaceuticals plc
CNTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,757 | $1,913 | $2,212 |
| - Cash | $51 | $44 | $105 | $383 |
| + Debt | $118 | $118 | $118 | $117 |
| Enterprise Value | – | $1,830 | $1,926 | $1,946 |
| Revenue | $0 | $0 | $15 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $15 | $0 |
| % Margin | – | – | 100% | – |
| EBITDA | -$52 | -$46 | -$22 | -$108 |
| % Margin | – | – | -144.3% | – |
| Net Income | -$55 | -$50 | -$26 | -$111 |
| % Margin | – | – | -174.2% | – |
| EPS Diluted | -0.41 | -0.38 | -0.2 | -0.84 |
| % Growth | -7.9% | -90% | 76.2% | – |
| Operating Cash Flow | -$58 | -$22 | -$57 | -$43 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$59 | -$23 | -$57 | -$43 |